
BlackRock Health Sciences Opportunities Portfolio
BHSRX
Updated: 03/11/2026, 13:01:23
No historical data available
This investment portfolio commits a significant portion—at least 80%—of its total assets to equity securities, predominantly common stocks, of companies operating within the health sciences sector and its related industries. This broad sector encompasses diverse sub-industries, including but not limited to, manufacturers of healthcare equipment and supplies, providers of healthcare services, biotechnology firms, and pharmaceutical companies. The fund further implements a concentrated investment approach, dedicating more than 25% of its assets to these health sciences or associated fields. Additionally, it possesses the discretion to invest in companies situated in international markets.
No summaries found.
- Share price
- $64.95
- Market cap
- $6.21B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 09/09/2011
- Beta
- 0.482
- Last dividend
- $0.00
- Day range
- $64.95 – $65.52
- 52-week range
- $57.51 – $66.77
- 1-day performance
- -0.87%
- 1-year performance
- 12.94%
- Current drawdown (1Y)
- -2.73%
- CIK
- 0000844779
- CUSIP
- 091936815
- ISIN
- US0919368151
- Created
- 07/12/2025, 02:59:16
- Last update
- 03/11/2026, 13:01:23
Track BlackRock Health Sciences Opportunities Portfolio with an AI analyst
See which prediction-market events move BHSRX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.